跳至主要内容
临床试验/NCT02418065
NCT02418065Unknown3 期

Multimodal Therapeutic Approach by Exercise, Oral Nutritional Supplementation, Omega 3 and Androgen in Undernourished Maintenance Hemodialysis Patients (AMERICANO)

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2013年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
120
试验地点
1
主要终点
Change of physical endurance on bicycle

研究概览

简要总结

The aim of the study is to evaluate a 3 months integrated multimodal therapeutic approach including exercise training program with ergocycle during dialysis sessions, oral nutritional supplementation, omega 3 and androgen, on effort tolerance and quality of life of under-nourish maintenance hemodialysis Chronic Kidney Disease (CKD) patient.

详细描述

The aim of the study is to evaluate a 3 months integrated multimodal therapeutic approach including exercise training program with ergocycle during dialysis sessions, oral nutritional supplementation, omega 3 and androgen, on effort tolerance and quality of life of under-nourish maintenance hemodialysis Chronic Kidney Disease (CKD) patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hemodialysis patient since at least 6 month
  • Patient aged 18 years or older
  • Written consent to participate in the study
  • No acute infection or hospitalization
  • Opinion of Cardiologist saying there is no known evidence against the evaluation of the maximum exercise capacity
  • Protein-energy wasting diagnosed if at least two of this characteristics are present
  • Serum albumin <3.8 g per 100 ml (Bromcresol Green)
  • Serum prealbumin (transthyretin) <30mg per 100 ml
  • Reduce body mass (BMI <23)
  • Unintentional 10% weight loss over 6 months
  • Lean body mass index < 10th percentile

排除标准

  • Presence of comorbidity which compromising the survival within 6 month
  • Unintentional low DEI <20 kcal kg_1 day_1
  • HIV or HCV positive
  • History of hormone dependent cancer
  • Suspected or confirmed prostate cancer or breast carcinoma
  • Known hypersensitivity for testosterone
  • Presence or history of hepatic tumor
  • Inability to follow the rehabilitation program
  • Inadequate dialysis dosage (<12 hours / week or Kt/V index< 1,2) Pregnant or planning pregnancy and lactating women during study period
  • Adult patient protected by law
  • Patient who don't sign his informed consent

研究组 & 干预措施

treated group

Experimental

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

干预措施: training on ergonomic bicycle (Other)

treated group

Experimental

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

干预措施: Testosterone (Drug)

treated group

Experimental

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

干预措施: Oral nutritional supplementation (Drug)

treated group

Experimental

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

干预措施: n3 polyunsaturated fatty acid (Drug)

control group

Other

oral nutritional supplementation

干预措施: Oral nutritional supplementation (Drug)

结局指标

主要结局

Change of physical endurance on bicycle

时间窗: At months 3 and 15 after inclusion

Physical endurance on bicycle at intermediate power between maximal power and ventilatory threshold power (Pmax+Pthreshold)/2

次要结局

  • Health-related quality of life assessment using SF-36 scale and KDQOL(at day 1)
  • Karnofsky score(at ady 1)
  • determination of creatinine(µmol/L)(at 1 year)
  • Body composition(at day 1)
  • determination of urea (mmol/L)(at day 1)
  • Transthyrin serum concentration evolution(at day 1)
  • Maximal power on bicycle(at day 1)
  • Nutritional parameters(at day 1)
  • serum levels of albumin (g/L)(at day 1)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验